SBI Securities Co. Ltd. Buys New Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

SBI Securities Co. Ltd. bought a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 5,028 shares of the company's stock, valued at approximately $393,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. D1 Capital Partners L.P. acquired a new stake in GE HealthCare Technologies during the 3rd quarter valued at $268,159,000. Van ECK Associates Corp boosted its position in GE HealthCare Technologies by 107.3% in the 4th quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company's stock valued at $378,520,000 after buying an additional 2,506,417 shares during the last quarter. State Street Corp grew its stake in shares of GE HealthCare Technologies by 7.8% during the third quarter. State Street Corp now owns 18,615,890 shares of the company's stock valued at $1,747,101,000 after acquiring an additional 1,347,114 shares in the last quarter. Massachusetts Financial Services Co. MA purchased a new stake in shares of GE HealthCare Technologies during the third quarter worth about $93,713,000. Finally, Jennison Associates LLC increased its position in shares of GE HealthCare Technologies by 124.5% during the fourth quarter. Jennison Associates LLC now owns 1,709,635 shares of the company's stock worth $133,659,000 after acquiring an additional 948,017 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Stock Performance

GEHC traded up $1.17 during trading hours on Friday, hitting $86.58. The company's stock had a trading volume of 4,075,712 shares, compared to its average volume of 2,984,066. The company has a 50-day simple moving average of $86.63 and a 200 day simple moving average of $86.13. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $39.59 billion, a PE ratio of 20.00, a PEG ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80.

Remove Ads

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analysts' expectations of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. As a group, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Citigroup raised their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. Wells Fargo & Company raised their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.